Allergy Research Group ®
Lumbrokinase
(Fibrenase III)
To support the breaking up/dissolving of the
unhealthy coagulation of blood
(30 capsules - 230 mg) Lumbrokinase is an enzyme
derived from earthworms Lumbricus rubellus. Research has shown
lumbrokinase to support the body in breaking up and dissolving the
unhealthy coagulation of blood and to enhance fibrinolytic activity,
i.e. similar to nattokinase.
Lumbrokinase (LK) consists of a group of proteolytic
enzymes including plasminogen activator and plasmin extracted from a
specific species of earthworm. The plasminogen activator (e-PA) in LK is
similar to tissue plasminogen activator (t-PA) from other sources, which
makes it possible to show the thrombolytic activity only in the presence
of fibrin. Therefore, LK has the advantage of not causing excessive
bleeding. The activity of LK is much higher than most traditional
Chinese medicines that are available in the United States. Four phases
of clinical studies have been done on LK at the Beijing Xuanwu Hospital
(the top hospital in nerve & internal medicine in China). LK has been
widely used in over 100 hospitals in Beijing since 1995. In Jakarta, LK
has been used in thousands of hospitals and drug stores in more than 20
provinces and cities as well as in Hong Kong, Taiwan, Southeast Asia,
and Europe.
LK has a certificate of GMP for human drugs from the
SDA in China and is recognized as a state class new drug approved by the
Ministry of Public Health. LK capsules technology was awarded with a
certificate of National Significance Achievement in Science and
Technology listed as the Promotional project of National Key Technology
Achievement and the National Torch Plan Program, and selected as
National Key New product by 6 major ministries. It has been included in
the Medicines Catalog of National Fundamental Health Insurance and
awarded with gold prize at China's Achievement in Medicine and Public
Health Technology Fair. *
